Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 97

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Regulation of DNA Binding of p53 by its C-terminal Domain

Weinberg, Richard L., Freund, Stefan M.V., Veprintsev, Dmitry B., Bycroft, Mark, Fersht, Alan R. · 2004 · Journal of Molecular Biology

Abstract

The tumor suppressor p53 is a tetrameric multi-domain transcription factor. Its C-terminal domain is thought to regulate the binding of its core domain to specific recognition sequences in promoters. The mechanism of regulation by the C-terminal domain and the role of its post-translational modification are controversial. We have examined the binding of DNA in solution to a series of unmodified p53 constructs that lack various domains. The specific DNA sequences bind tightly to the core domain, irrespective of whether or not the C-terminal domain is part of the construct. Unmodified p53 is accordingly an active DNA binding protein. Non-specific DNA sequences do not inhibit directly the binding of the specific sequences to the core but bind to the C terminus and inhibit p53 via that binding mode. Using NMR, we identified the residues of the C terminus that interact with the non-specific DNA. They include residues that are known to be modified post-translationally. Our data provide direct support for the regulatory role of the C terminus in the activity of p53 and show that p53 containing the unmodified C terminus actively binds to short double-stranded DNA.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jmb.2004.07.042

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 40

  1. Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  2. Zhao, 2000, Analysis of p53-regulated gene expression patterns using oligonucleotide arrays, Genes Dev., 14, 981, 10.1101/gad.14.8.981 · DOI · Paper page
  3. Vousden, 2002, Live or let die: the cell's response to p53, Nature Rev. Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
  4. Fields, 1990, Presence of a potent transcription activating sequence in the p53 protein, Science, 249, 1046, 10.1126/science.2144363 · DOI · Paper page
  5. Walker, 1996, Identification of a novel p53 functinal domain that is necessary for efficient growth suppression, Proc. Natl Acad. Sci. USA, 93, 15335, 10.1073/pnas.93.26.15335 · DOI · Paper page
  6. Oliner, 1993, Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53, Nature, 362, 857, 10.1038/362857a0 · DOI · Paper page
  7. Thut, 1995, p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60, Science, 267, 100, 10.1126/science.7809597 · DOI · Paper page
  8. Lu, 1995, Human TAFII3 protein is a transcriptional co-activator of the p53 protein, Proc. Natl Acad. Sci. USA, 92, 5154, 10.1073/pnas.92.11.5154 · DOI · Paper page
  9. Bargonetti, 1993, A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein, Genes Dev., 7, 2565, 10.1101/gad.7.12b.2565 · DOI · Paper page
  10. Jeffrey, 1995, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7angstroms, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
  11. Clore, 1995, Refined solution structure of the oligomerization domain of the tumour suppressor p53, Nature Struct. Biol., 2, 321, 10.1038/nsb0495-321 · DOI · Paper page
  12. Clore, 1994, High-resolution structure of the oligomerization domain of p53 by multidimensional NMR, Science, 265, 386, 10.1126/science.8023159 · DOI · Paper page
  13. Yakovleva, 2002, p53 latency—out of the blind alley, Trends Biochem. Sci., 27, 612, 10.1016/S0968-0004(02)02209-0 · DOI
  14. Ahn, 2001, The C-terminus of p53: the more you learn the less you know, Nature Struct. Biol., 8, 730, 10.1038/nsb0901-730 · DOI
  15. Hupp, 1995, Small peptides activate the latent sequence-specific DNA binding function of p53, Cell, 83, 237, 10.1016/0092-8674(95)90165-5 · DOI · Paper page
  16. Hupp, 1994, Allosteric activation of latent p53 tetramers, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0 · DOI · Paper page
  17. Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  18. Ayed, 2001, Latent and active p53 are identical in conformation, Nature Struct. Biol., 8, 756, 10.1038/nsb0901-756 · DOI
  19. Yakovleva, 2001, p53 latency—C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences, J. Biol. Chem., 276, 15650, 10.1074/jbc.M100482200 · DOI
  20. Kim, 1999, Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53, Oncogene, 18, 7310, 10.1038/sj.onc.1203139 · DOI
  21. Kim, 1997, DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53, Oncogene, 15, 857, 10.1038/sj.onc.1201412 · DOI
  22. Kaeser, 2002, Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl Acad. Sci. USA, 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
  23. Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
  24. Bayle, 1995, The carboxy-terminal domain of the p53 protein regulates sequence-specific DNA binding through its non-specific nucleic acid-binding activity, Proc. Natl Acad. Sci. USA, 92, 5729, 10.1073/pnas.92.12.5729 · DOI
  25. Anderson, 1997, Reciprocal interference between the sequence-specific core and non-specific C-terminal DNA binding domains of p53: implications for regulation, Mol. Cell. Biol., 17, 6255, 10.1128/MCB.17.11.6255 · DOI
  26. LeTilly, 1993, Fluorescence anisotropy assays implicate protein–protein interactions in regulating trp repressor DNA binding, Biochemistry, 32, 7753, 10.1021/bi00081a021 · DOI
  27. Funk, 1992, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol., 12, 2866, 10.1128/MCB.12.6.2866 · DOI · Paper page
  28. Mujtaba, 2004, Structural mechanism of the bromodomain of the coactivator CP in p53 transcriptional activation, Mol. Cell, 13, 251, 10.1016/S1097-2765(03)00528-8 · DOI · Paper page
  29. Rustandi, 2000, Structure of the negative regulatory domain of p53 bound to S100B, Nature Struct. Biol., 7, 570, 10.1038/76797 · DOI
  30. Record, 1991, Analysis of equilibrium and kinetic measurements to determine thermodynamic origins of stability and specificity and mechanism of formation of site-specific complexes between proteins and helical DNA, Methods Enzymol., 208, 291, 10.1016/0076-6879(91)08018-D · DOI · Paper page
  31. Prives, 2001, Why is p53 acetylated?, Cell, 107, 815, 10.1016/S0092-8674(01)00619-5 · DOI · Paper page
  32. Barlev, 2001, Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases, Mol. Cell, 8, 1243, 10.1016/S1097-2765(01)00414-2 · DOI · Paper page
  33. Jiao, 2001, Dynamic interactions of p53 with DNA in solution by time-lapse atomic force microscopy, J. Mol. Biol., 314, 233, 10.1006/jmbi.2001.5129 · DOI
  34. Midgley, 1992, Analysis of p53 expression in human tumors—an antibody raised against human P53 expressed in Escherichia coli, J. Cell Sci., 101, 183, 10.1242/jcs.101.1.183 · DOI · Paper page
  35. Miroux, 1996, Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels, J. Mol. Biol., 260, 289, 10.1006/jmbi.1996.0399 · DOI · Paper page
  36. Neidhardt, 1974, Culture medium for enterobacteria, J. Bacteriol., 119, 736, 10.1128/JB.119.3.736-747.1974 · DOI · Paper page
  37. Gill, 1989, Calculation of protein extinction coefficients from amino acid sequence data, Anal. Biochem., 182, 319, 10.1016/0003-2697(89)90602-7 · DOI · Paper page
  38. Johnson, 1994, NMR View - computer program for the visualization and analysis of NMR data, J. Biomol. NMR, 4, 603, 10.1007/BF00404272 · DOI · Paper page
  39. Hajduk, 1997, NMR-based discovery of lead inhibitors that block DNA binding of the human papilomavirus E2 proein, J. Med. Chem., 40, 3144, 10.1021/jm9703404 · DOI · Paper page
  40. Weinberg, 2004, Cooperative binding of tetrameric p53 to DNA, J. Mol. Biol., 341, 1145, 10.1016/j.jmb.2004.06.071 · DOI · Paper page

Cited by

See all 97

Metadata

Authors
Weinberg, R. L., Freund, S. M. V., Veprintsev, D. B., Bycroft, M., & Fersht, A. R.
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2004-09
Volume
342
Issue
3
Pages
801-811
ISSN
0022-2836
Cited by
97
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.